{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T09:07:00Z","timestamp":1746004020118,"version":"3.40.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fondo per il Programma Nazionale di Ricerca e Progetti di Rilevante Interesse Nazionale - PRIN","award":["2022ZKKWLW"],"award-info":[{"award-number":["2022ZKKWLW"]}]},{"name":"Societ\u00e0 Italiana di Medicina Interna \u2013 SIMI"},{"name":"Unione Europea \u201cNational Center for Gene Therapy and Drugs based on RNA Technology\u201d, PNRR missione 4 \u2013 componente 2 \u2013 investimento 1.4","award":["CN00000041"],"award-info":[{"award-number":["CN00000041"]}]},{"name":"Italian network of excellence for advanced diagnosis (INNOVA), Ministero della Salute","award":["PNC-E3-2022-23683266 PNC-HLS-DA"],"award-info":[{"award-number":["PNC-E3-2022-23683266 PNC-HLS-DA"]}]},{"name":"Complementary National Plan PNC-I.1 \"Research initiatives for innovative technologies and pathways in the health and welfare sector\u201d","award":["PNC0000002"],"award-info":[{"award-number":["PNC0000002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02207-w","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T17:00:52Z","timestamp":1743267652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful rapid desensitization to zoledronic acid in a multiple myeloma patient"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8373-0532","authenticated-orcid":false,"given":"Federico","family":"Spataro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2293-9698","authenticated-orcid":false,"given":"Antonio Giovanni","family":"Solimando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Desantis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"12","key":"2207_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/cancers12010173","volume":"10","author":"L Rao","year":"2020","unstructured":"Rao L, Giannico D, Leone P, Solimando AG, Maiorano E, Caporusso C, Duda L, Tamma R, Mallamaci R, Susca N, Buonavoglia A, Da Vi\u00e0 MC, Ribatti D, De Re V, Vacca A, Racanelli V. HB-EGF-EGFR signaling in bone marrow endothelial cells mediates angiogenesis associated with multiple myeloma. Cancers (Basel). 2020;10(12):173.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2207_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/jcm9020552","volume":"18","author":"G Di Lernia","year":"2020","unstructured":"Di Lernia G, Leone P, Solimando AG, Buonavoglia A, Saltarella I, Ria R, Ditonno P, Silvestris N, Crudele L, Vacca A, Racanelli V. Bortezomib treatment modulates autophagy in multiple myeloma. J Clin Med. 2020;18(9):552.","journal-title":"J Clin Med"},{"issue":"110","key":"2207_CR3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2007-03-067710","volume":"15","author":"E Terpos","year":"2007","unstructured":"Terpos E, Sezer O, Croucher P, Dimopoulos MA. Myeloma bone disease and proteasome inhibition therapies. Blood. 2007;15(110):1098\u2013104.","journal-title":"Blood"},{"key":"2207_CR4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S1470-2045(18)30072-X","volume":"19","author":"N Raje","year":"2018","unstructured":"Raje N, Terpos E, Willenbacher W, Shimizu K, Garc\u00eda-Sanz R, Durie B, Legie\u0107 W, Krej\u010d\u00ed M, Laribi K, Zhu L, Cheng P, Warner D, Roodman GD. Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study. Lancet Oncol. 2018;19:370\u201381.","journal-title":"Lancet Oncol"},{"key":"2207_CR5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imlet.2018.04.007","volume":"205","author":"M Bolzoni","year":"2019","unstructured":"Bolzoni M, Toscani D, Costa F, Vicario E, Aversa F, Giuliani N. The link between bone microenvironment and immune cells in multiple myeloma: emerging role of CD38. Immunol Lett. 2019;205:65\u201370.","journal-title":"Immunol Lett"},{"issue":"9","key":"2207_CR6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3390\/cancers11091270","volume":"11","author":"A Argentiero","year":"2019","unstructured":"Argentiero A, Solimando AG, Brunetti O, Calabrese A, Pantano F, Iuliani M, Santini D, Silvestris N, Vacca A. Skeletal metastases of unknown primary: biological landscape and clinical overview. Cancers (Basel). 2019;11(9):1270.","journal-title":"Cancers (Basel)"},{"key":"2207_CR7","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1007\/s10238-023-01100-6","volume":"23","author":"M Bittrich","year":"2023","unstructured":"Bittrich M, Hetterich R, Solimando AG, Krebs M, Loda S, Danhof S, Anton S, Zhou X, Kerscher A, Beilhack A, Kort\u00fcm KM, Rasche L, Einsele H, Knop S, Hartmann S. Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma? Exploring a large single center database using artificial intelligence. Clin Exp Med. 2023;23:5215\u201326.","journal-title":"Clin Exp Med"},{"key":"2207_CR8","unstructured":"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2014\/021223s028lbl.pdf. Accessed 10th Mar 2024."},{"key":"2207_CR9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1398-9995.2010.02441.x","volume":"65","author":"JR Cernadas","year":"2010","unstructured":"Cernadas JR, Brockow K, Romano A, et al. General considerations on rapid desensitization for drug hypersensitivity\u2013a consensus statement. Allergy. 2010;65:1357\u201366.","journal-title":"Allergy"},{"key":"2207_CR10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","volume":"122","author":"MC Castells","year":"2008","unstructured":"Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, Laidlaw TM, Legere HJ, Nallamshetty SN, Palis RI, Rao JJ, Berlin ST, Campos SM, Matulonis UA. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol. 2008;122:574\u201380.","journal-title":"J Allergy Clin Immunol"},{"key":"2207_CR11","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","volume":"8","author":"AD Broyles","year":"2020","unstructured":"Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ, Breslow RG, Brockow K, Buchheit KM, Cahill KN, Cernadas J, Chiriac AM, Crestani E, Demoly P, Dewachter P, Dilley M, Farmer JR, Foer D, Fried AJ, Garon SL, Giannetti MP, Hepner DL, Hong DI, Hsu JT, Kothari PH, Kyin T, Lax T, Lee MJ, Lee-Sarwar K, Liu A, Logsdon S, Louisias M, MacGinnitie A, Maciag M, Minnicozzi S, Norton AE, Otani IM, Park M, Patil S, Phillips EJ, Picard M, Platt CD, Rachid R, Rodriguez T, Romano A, Stone CA Jr, Torres MJ, Verd\u00fa M, Wang AL, Wickner P, Wolfson AR, Wong JT, Yee C, Zhou J, Castells M. Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs. J Allergy Clin Immunol Pract. 2020;8:S16\u2013116.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"17","key":"2207_CR12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s13023-022-02556-7","volume":"3","author":"F Spataro","year":"2022","unstructured":"Spataro F, Viggiani F, Macchia DG, Rollo V, Tummolo A, Suppressa P, Sabba\u2019 C, Rossi MP, Giliberti L, Satriano F, Nettis E, Di Bona D, Caiaffa MF, Fischetto R, Macchia L. Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS). Orphanet J Rare Dis. 2022;3(17):402.","journal-title":"Orphanet J Rare Dis"},{"key":"2207_CR13","doi-asserted-by":"crossref","first-page":"e13981","DOI":"10.1111\/pai.13981","volume":"34","author":"F Spataro","year":"2023","unstructured":"Spataro F, Carlucci P, Loverre T, Macchia L, Di Bona D. Hypersensitivity reaction during enzyme replacement therapy in lysosomal storage disorders. A systematic review of desensitization strategies. Pediatr Allergy Immunol. 2023;34:e13981.","journal-title":"Pediatr Allergy Immunol"},{"issue":"19","key":"2207_CR14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13023-024-03516-z","volume":"27","author":"F Spataro","year":"2024","unstructured":"Spataro F, Ria R, Chaoul N, Solimando AG, Desantis V, Vacca A, Di Bona D, Girolamo AD, Macchia L. Two-year follow-up after drug desensitization in mucopolysaccharidosis. Orphanet J Rare Dis. 2024;27(19):491.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2207_CR15","doi-asserted-by":"crossref","first-page":"12558","DOI":"10.1038\/s41598-021-91851-7","volume":"15","author":"A Vultaggio","year":"2021","unstructured":"Vultaggio A, Nencini F, Bormioli S, Silvestri E, Dies L, Vivarelli E, Maggi E, Matucci A. Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis. Sci Rep. 2021;15(11):12558.","journal-title":"Sci Rep"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02207-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02207-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T17:01:29Z","timestamp":1743267689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02207-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02207-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Ethical Committee of Bari University Hospital (reference number 1300, 21.12.2023). Informed consent was obtained from the patient to participate in the study. The participant was aware of the purpose of the procedure, its risks, and its benefits.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patient for the publication of identifying information and images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"401"}}